Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Focused Extracorporeal Shock Wave Therapy Applied as an Addition to Conventional Physiotherapy Program After Anterior Cruciate Ligament Reconstruction

NCT06688344 is registered in ClinicalTrials.gov with Berivan Beril Kılıç as lead sponsor.

NCT NCT06688344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06688344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Focused Extracorporeal Shock Wave Therapy Applied as an Addition to Conventional Physiotherapy Program After Anterior Cruciate Ligament Reconstruction
Lead sponsor
Berivan Beril Kılıç
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2024
Completion date
May 1, 2027
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acl reconstruction, extracorpereal shock wave therapy